medigraphic.com

2018, Número 3

<< Anterior Siguiente >>

Rev Mex Anest 2018; 41 (3)


Consenso multidisciplinario para el manejo de la hemorragia obstétrica en el perioperatorio

Carrillo-Esper R, de la Torre-León T, Nava-López JA, Posada-Nava A, Pérez-Calatayud ÁA, de la Torre-León MA, Cabello-Aguilera R, López-Gutiérrez MR

Idioma: Español
Referencias bibliográficas: 114
Paginas: 155-182
Archivo PDF: 358.03 Kb.


RESUMEN

La muerte materna tiene un carácter de prevención y por lo tanto evitable, esto constituye un problema de derechos humanos, equidad de género y justicia social. Una de las principales estrategias para disminuir la presencia de hemorragia obstétrica y sus complicaciones es protocolizar el manejo e identificar de manera oportuna los factores de riesgo para el desarrollo de esta complicación. Se propone un consenso de expertos para el manejo de esta causa importante de muerte materna en el perioperatorio, con el objetivo de unificar la toma de decisiones clínicas en los tres niveles de atención referentes a la hemorragia obstétrica en el perioperatorio con base en las recomendaciones sustentadas con evidencia actual y disponible. El consenso se presenta como un listado de recomendaciones para cada pregunta del tema seleccionado. Se realizó la búsqueda en PubMed y Cochrane Library Plus de guías de práctica clínica, revisiones sistemáticas, ensayos clínicos aleatorizados, metaanálisis y reportes clínicos. Los resultados se expresaron en niveles de evidencia y grados de recomendación de acuerdo con las características del diseño y tipo de estudio. Es prioritario el manejo adecuado de la paciente que cursa con hemorragia obstétrica; la toma de decisiones se debe adaptar al contexto clínico de la paciente.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Freyermuth E, Luna M. Muerte materna y muertes evitables en exceso. En: Ordaz L. Revista internacional de estadística y geografía. Vol. 5. México: Instituto Nacional de Estadística y Geografía; 2014. pp. 44-51.

  2. Dirección general de epidemiología, Informe semanal de vigilancia epidemiológica, defunciones maternas, información al 16 de octubre de ambos años, SINAVE, DGE [Internet]. 2017 [Citado 01 Ene 2018]. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/264540/MMAT_2017_SE41.pdf

  3. Morillas-Ramíreza F, Ortiz-Gómezb JR, Palacio-Abizanda FJ, Fornet-Ruizc I, Pérez-Lucas R, Bermejo-Albares L. Actualización del protocolo de tratamiento de la hemorragia obstétrica. Rev Esp Anestesiol Reanim. 2014;61:196-204.

  4. Organización Mundial de la Salud, Recomendaciones de la OMS para la prevención y el tratamiento de la hemorragia postparto. Suiza, 2014.

  5. Sainio S, Kekomäki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population based study. Acta Obstet Gynecol Scand. 2000;79:744-749.

  6. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266-273.

  7. Guasch E, Gilsanz F. Hemorragia masiva obstétrica: enfoque terapéutico actual. Med Intensiva. 2016;40:298-310.

  8. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3:1894-1904.

  9. Hiipala ST. Dextran and hydroethyl starch interfere with fibrinogen assays. Blood Coagulation & Fibrinolysis. 1995;6:743-746.

  10. Adler G, Duchinski T, Jasinska A, Piotrowska U. Fractions in the third trimester of pregnancy and in puerperium. Thromb Res. 2000;97:405-410.

  11. Mutoh T, Kazumata K, Terasaka S, Taki Y, Suzuki A, Ishikawa T. Early intensive versus minimally invasive approach to postoperative hemodynamic management after subarachnoid hemorrhage. Stroke. 2014;45:1280-1284.

  12. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926.

  13. Vincent JL. Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol. 2009;23:183-191.

  14. Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2017;34:332-395.

  15. Begley CM, Gyte GML, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2015;(3):CD007412.

  16. Tsen LC, Balki M. Oxytocin protocols during cesarean delivery: time to acknowledge the risk/benefit ratio? Int J Obstet Anesth. 2010;19:243-245.

  17. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104:1005-1010.

  18. Representantes del Grupo Desarrollador de la Guía, Guía de práctica clínica para la prevención y el manejo de la hemorragia postparto y complicaciones del choque hemorrágico. Rev Colomb Obstet Ginecol. 2013;64:425-452.

  19. Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. London; 2016 [Visitado 2018 Feb 1]. Available in: http://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg52/).

  20. Elbourne DR, Prendiville WJ, Carroli G, Wood J, McDonald S. Prophylactic use of oxytocin in the third stage of labour. Cochrane Database Syst Rev. 2001;(4):CD001808.

  21. Dennehy KC, Rosaeg OP, Cicutti NJ, Krepski B, Sylvain JP. Oxytocin injection after caesarean delivery: intravenous or intramyometrial? Can J Anaesth. 1998;45:635-639.

  22. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC. Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2001;98:386-390.

  23. George RB, McKeen D, Chaplin AC, McLeod L. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterineatony in parturients undergoing Cesarean delivery. Can J Anaesth. 2010;57:578-582.

  24. Svanström MC, Biber B, Hanes M, Johansson G, Näslund U, Bålfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth. 2008;100:683-689.

  25. Leduc D, Senikas V, Lalonde AB. Clinical Practice Obstetrics Committee. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009;31:980-993.

  26. Gómez-Dávila JG, Osorio-Castaño JH, Vélez-Álvarez GA, Zuleta-Tobón JJ, Londoño-Cardona JG, Velásquez-Penagos JA. Guía de práctica clínica para la prevención y el manejo de la hemorragia postparto y complicaciones del choque hemorrágico. Rev Colomb Obstet Ginecol. 2013;64:425-452.

  27. Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, et al. Postpartum haemorrhage, prevention and management of posptartum haemorrhage. Royal College of Obstetricians & Gynaecologists. BJOG. 2016;124:e106-e114.

  28. Lalonde A. International Federation of Gynecology and Obstetrics. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2012;117:108-118.

  29. World Health Organization. Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva: WHO; 2012 [citado 2018 Mar 1].

  30. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010;(7):CD007872.

  31. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med. 2009;22:72-75.

  32. Martínez-de los Santos CA, Espinoza de los Monteros-Estrada I. Alternativas en el manejo de la hemorragia aguda en el transoperatorio. Rev Mex Anest. 2016;39:276-280.

  33. Secretaría de Salud. Triage Obstétrico, Código Mater y Equipo de Respuesta Inmediata Obstétrica. México, 2016.

  34. ACLS, [Internet]. Algorithms for Advanced Cardiac Life Support, 2017 [citado Febrero 2018] Available in: https://www.acls.net/aclsalg.htm.

  35. NHS Post Partum Haemorrhage (PPH). Clinical Guideline For Management 2017.

  36. Hernández-Morales MA, García-de la Torre JI. Factores de riesgo de hemorragia obstétrica. Ginecol Obstet Mex. 2016;84:757-764.

  37. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Critical Care. 2016;20:100.

  38. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the past, present and future. Int J Obstet Anesth. 2013;22:87-91.

  39. Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: Diagnosis and management. Green-top Guideline. 2011; p. 27.

  40. Carrillo-Esper R, Zaragoza-Lemus G. Guía de práctica clínica basada en la evidencia para el manejo de anestesia regional y anticoagulación. Rev Mex Anest. 2009;32:247-276.

  41. Nguyen-Lu N, Carvalho JC, Kingdom J, Windrim R, Allen L, Balki M. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. Can J Anesth. 2016;63:1233-1244.

  42. Royal College of Obstetricians and Gynaecologists. Prevention and Management of Post-Partum Haemorrhage. RCOG Green-top Guideline. 2011;52:1-24.

  43. Sentilhes L, Vayssière C, Deneux-Tharaux C, Aya AG, Bayoumeu F, Bonnet MP, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12-21.

  44. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 Update. Crit Care Med. 2004;32:1928-1948.

  45. Snegovskikh D, Clebone A, Norwitz E. Anesthetic management of patients with placenta accreta and resuscitation strategies for associated massive hemorrhage. Curr Opin Anaesthesiol. 2011;24:274-281.

  46. Zeidler K, Arn K, Senn O, Schanz U, Stussi G. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion. 2011;51:2269-2276.

  47. McGee C, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;12:1123-1233.

  48. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270-382.

  49. Rajagopalan S, Mascha E, Na J, Sessler DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology. 2008;108:71-77.

  50. Ireland S, Endacott R, Cameron P, Fitzgerald M, Paul E. The incidence and significance of accidental hypothermia in major trauma. A prospective observational study. Resuscitation. 2011;82:300-306.

  51. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795-1815.

  52. Yunos NM, Bellomo R, Glassford N, Sutcliffe H, Lam Q, Bailey M. Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis. Intensive Care Med. 2015;41:257-264.

  53. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double blind crossover study on the effects of 2-l infusions of 0.9% saline and plasma-Lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18-24.

  54. Patel N, Baker SM, Walters RW, Kaja A, Kandasamy V, Abuzaid A, et al. Serum hyperchloremia as a risk factor for acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Proc (Bayl Univ Med Cent). 2016;29:7-11.

  55. Zazzeron, Gattinoni L, Caironi P. Role of albumin, starches and gelatins versus crystalloids in volume resuscitation of critically ill patients. Curr Opin Crit Care. 2016;22:428-3659.

  56. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? Chest. 2008;134:172-178.

  57. Magder S. Central venous pressure: a useful but not so simple measurement. Crit Care Med. 2006;34:2224-2227.

  58. Vandromme MJ, Griffin RL, Weinberg JA, Rue LW 3rd, Kerby JD. Lactate is a better predictor than systolic blood pressure for determining blood requirement and mortality: could prehospital measures improve trauma triage? J Am Coll Surg. 2010;210:861-867.

  59. Callaway DW, Shapiro NI, Donnino MW, Baker C, Rosen CL. Serum lactate and base deficit as predictors of mortality in normotensive elderly blunt trauma patients. J Trauma. 2009;66:1040-1044.

  60. Walley KR. Use of central venous oxygen saturation to guide therapy. Am J Respir Crit Care Med. 2011;184:514-520.

  61. Del Portal DA, Shofer F, Mikkelsen ME, Dorsey PJ Jr, Gaieski DF, Goyal M, et al. Emergency department lactate is associated with mortality in older adults admitted with and without infections. Acad Emerg Med. 2010;17:260-268.

  62. Zhang Z, Xu X. Lactate clearance is a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2014;42:2118-2125.

  63. Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in Intensive Care Unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752-761.

  64. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739-746.

  65. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, Ddungu H, Kyeyune D, Musisi E, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia. JAMA. 2015;23:2510-2514.

  66. Sakr Y, Chierego M, Piagnerelli M, Verdant C, Dubois MJ, Koch M, et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med. 2007;35:1639-1644.

  67. Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627-634.

  68. Popel AS, Johnson PC. Microcirculation and hemorheology. Annu Rev Fluid Mech. 2005;37:43-69.

  69. Adeva-Andany MM, Fernández-Fernández C, Mouriño-Bayolo D, Castro-Quintela E, Domínguez-Montero A. Sodium bicarbonate therapy in patients with metabolic acidosis. Sci World J. 2014;2014:627673.

  70. Wilson RF, Spencer AR, Tyburski JG, Dolman H, Zimmerman LH. Bicarbonate therapy in severely acidotic trauma patients increases mortality. J Trauma Acute Care Surg. 2013;1:45-50.

  71. Mark NH, Leung JM, Arieff AI, Mangano DT. Safety of low dose intraoperative bicarbonate therapy: A prospective, double-blind, randomized study. The Study of Perioperative Ischemia (SPI) Research Group. Crit Care Med. 1993;21:659-665.

  72. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L. Acute respiratory distress syndrome The Berlin definition. JAMA. 2012;23:2526-2533.

  73. Mulder HD, Augustijn QJ, van Woensel JB, Bos AP, Juffermans NP, Wösten-van Asperen RM. Incidence, risk factors, and outcome of transfusion-related acute lung injury in critically ill children: a retrospective study. J Crit Care. 2015;30:55-59.

  74. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: An expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38:1573-1582.

  75. Shander A, Javidroozi M, Naqvi S, Aregbeyen O, Caylan M, Demir S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion. 2014;54:2688-2695.

  76. Domen RE. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion. 1998;38:296-300.

  77. Mulay SB, Jaben EA, Johnson P, Badjie K, Stubbs JR. Risks and adverse outcomes associated with emergency-release red blood cell transfusion. Transfusion. 2013;53:1416-1420.

  78. Seheult JN, Triulzi DJ, Alarcon LH, Sperry JL, Murdock A, Yazer MH. Measurement of haemolysis markers following transfusion of uncrossmatched, low-titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre. Transfus Med. 2017;27:30-35.

  79. Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114:409-414.

  80. Pacheco LD, Saade GR, Costantine MM, Clark SL, Hankins GD. An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 2016;214:340-344.

  81. Walsh M, Fritz S, Hake D, Son M, Greve S, Jbara M, et al. Targeted thromboelastographic (TEG) blood component and pharmacologic hemostatic therapy in traumatic and acquired coagulopathy. Curr Drug Targets. 2016;17:954-970.

  82. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion. 2014;54:1389-1405.

  83. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14:R55.

  84. Cohn SM, McCarthy J, Stewart RM, Jonas RB, Dent DL, Michalek JE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg. 2011;35:430-439.

  85. Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000494.

  86. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2007;(1):CD003249.

  87. McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2004;(1):CD000201.

  88. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2012;(3):CD005011.

  89. Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C. Association between fibrinogen level and severity of postpartum haemorrhage: Secondary analysis of a prospective trial. Br J Anaesth. 2012;108:984-989.

  90. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia. 2015;70:166-175.

  91. Wikkelsø AJ, Edwards HM, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, Ekelund K, et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth. 2015;114:623-633.

  92. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15:R117.

  93. Perel P, Ker K, Morales CH, Roberts I. Tranexamic acid for reducing mortality in emergency and urgent surgery. Cochrane Database Syst Rev. 2013;(1):CD010245.

  94. Dennis AT, Griffiths JD. Tranexamic acid for post-partum haemorrhage in the WOMAN trial. Lancet. 2017;10102:1582.

  95. Gillissen A, Henriquez DDCA, Van den Akker T, et al. The effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: a nationwide retrospective cohort study. PLoS One. 2017;12:e0187555.

  96. B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997;104:372-375.

  97. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstet Gynecol. 2002;99:502-506.

  98. Ghezzi F, Cromi A, Uccella S, Raio L, Bolis P, Surbek D. The Hayman technique: a simple method to treat postpartum haemorrhage. BJOG. 2007;114:362-365.

  99. Hwu YM, Chen CP, Chen HS, Su TH. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG. 2005;112:1420-1423.

  100. Representantes del Grupo Desarrollador de la Guía, Diagnóstico y tratamiento del choque hemorrágico en obstetricia. Guía de Evidencias y Recomendaciones: Guía de Práctica Clínica. México. CENETEC; 2017.

  101. Posadas-Nava A, Moreno-Santillán AA, Celis-González C, Cruz-Martínez E. Descripción de la técnica Posadas. Ginecol Obstet Mex. 2016;84:808-813.

  102. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007;62:540-547.

  103. Tsirulnikov MS. Ligation of the uterine vessels during obstetrical hemorrhages. Immediate and long-term results (author’s transl). J Gynecol Obstet Biol Reprod (Paris). 1979;8:751-753.

  104. AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrolled postpartum hemorrhage with preservation of the uterus. Am J Obstet Gynecol. 1994;171:694-700.

  105. Sandoval García-Travesí FA, Hinojosa-Cruz JC, Reyes-Hernández MU, Sandoval-Barajas D, Lorca-Jiménez G, Mendoza-Reyes E y cols. Tratamiento de la hemorragia postparto con condón hidrostático intrauterino. Ginecol Obstet Mex. 2016;84:243-251.

  106. Norma Oficial Mexicana NOM-006-SSA3-2011 Para la práctica de la anestesiología. Autor corporativo: Secretaría de salud. Diario Oficial de la Federación el 23 de marzo de 2012.

  107. Zeeman G. Obstetric critical care: A blueprint for improved outcomes. Crit Care Med. 2006;34:S208-S214.

  108. World Health Organization. Evaluating the quality of care for severe pregnancy complications: the WHO near miss approach for maternal Health; 2011.

  109. Martin W, Hutchon S. Multidisciplinary training in obstetric critical care. Best Pract Res Clin Obstet Gynaecol. 2008;22:953-964.

  110. Satava RM, Cuschieri A, Hamdorf J; Metrics for Objective Assessment of Surgical Skills Workshop. Metrics for objective assessment. Surg Endosc. 2003;17:220-226.

  111. Flores-Villalba E, Díaz-Elizondo JA, Leyva-Alvizo A, Fernández-Rangel E, Villegas-Cabello O, Real-Romo Z. Evaluación de un simulador quirúrgico en función de su desempeño al ser utilizado por residentes con diferentes grados de experiencia. Cir Cir. 2012;80:157-161.

  112. Gaba DM. The future vision of simulation in health care. Qual Saf Health Care. 2004;13:2-10.

  113. López-Moreno, Martínez-Ojeda R, López-Arellano O. Organización del abasto de medicamentos en los servicios estatales de salud. Potenciales consecuencias de la mezcla público-privada. Salud Pública Méx. 201;53:S445-457.

  114. Norma Oficial Mexicana NOM-253-c de sangre humana y sus componentes con fines terapéuticos.




2020     |     www.medigraphic.com